Recent advances in the understanding and management of mucormycosis

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
invasive aspergillosis 4 infectiousdiseases
AIDS 1 infectiousdiseases
aspergillosis 4 infectiousdiseases

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
AIDS 6547 known to inhibit Mucorales spore germination. This includes patients with hematological disorders, AIDS , or liver cirrhosis, those who have undergone solid organ transplant, and those being treated with high-dose
aspergillosis 2559 reasons [6]. Firstly, diagnosis is difficult because of clinico-radiological similarities with invasive aspergillosis and historical lack of diagnostic tools. However, new tools in serum and tissue as well as the recognition
aspergillosis 7795 associated with high mortality, especially in hematological patients. Early distinction from invasive aspergillosis is of utmost importance, as antifungal treatment may differ, whereas underlying conditions and clinical
aspergillosis 8169 delay.Figure 3. Mucormycosis: from suspicion to treatment.PCR, polymerase chain reaction.Unlike invasive aspergillosis , the detection of circulating antigen such as galactomannan and β-D-1,3-glucan provides no help for
aspergillosis 14994 mortality despite the availability of therapeutic tools. Determining whether the patient has invasive aspergillosis or mucormycosis could be challenging at the bedside. In this context, new tools of molecular biology
invasive aspergillosis 2550 several reasons [6]. Firstly, diagnosis is difficult because of clinico-radiological similarities with invasive aspergillosis and historical lack of diagnostic tools. However, new tools in serum and tissue as well as the recognition
invasive aspergillosis 7786 it is associated with high mortality, especially in hematological patients. Early distinction from invasive aspergillosis is of utmost importance, as antifungal treatment may differ, whereas underlying conditions and clinical
invasive aspergillosis 8160 diagnosis delay.Figure 3. Mucormycosis: from suspicion to treatment.PCR, polymerase chain reaction.Unlike invasive aspergillosis , the detection of circulating antigen such as galactomannan and β-D-1,3-glucan provides no help for
invasive aspergillosis 14985 incidence and mortality despite the availability of therapeutic tools. Determining whether the patient has invasive aspergillosis or mucormycosis could be challenging at the bedside. In this context, new tools of molecular biology

You must be authorized to submit a review.